GERN - Geron Corp.
IEX Last Trade
4.75
0.190 4.000%
Share volume: 11,113,159
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$4.56
0.19
4.17%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-07 | 2023-03-16 | 2023-05-11 | 2023-08-03 | 2023-11-02 | 2024-02-28 | 2024-05-02 | |
| Assets | |||||||||
| Total Assets | 238.161 M | 232.606 M | 190.575 M | 424.877 M | 415.296 M | 413.017 M | 394.076 M | 482.074 M | |
| Current Assets | 227.375 M | 222.070 M | 180.246 M | 387.023 M | 377.279 M | 335.085 M | 341.348 M | 451.509 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.470 M | 4.696 M | 3.992 M | 4.321 M | 4.179 M | 6.268 M | 4.879 M | 5.712 M | |
| Short Term Investments | 3.470 M | 4.696 M | 3.992 M | 4.321 M | 4.179 M | 6.268 M | 4.879 M | 5.712 M | |
| Total Receivables | 4.254 M | 22.223 M | 3.144 M | 1.596 M | 1.187 M | 14.754 M | 1.655 M | 1.629 M | |
| Current Cash | 219.287 M | 194.787 M | 172.746 M | 380.741 M | 371.378 M | 313.527 M | 333.699 M | 443.049 M | |
| Total Non-current Assets | 10.786 M | 10.536 M | 10.329 M | 37.854 M | 38.017 M | 77.932 M | 52.728 M | 30.565 M | |
| Property Plant Equipment | 641.000 K | 733.000 K | 793.000 K | 1.066 M | 1.147 M | 1.231 M | 1.177 M | 1.681 M | |
| Other Assets | 5.703 M | 5.507 M | 5.389 M | 4.693 M | 4.748 M | 5.197 M | 4.697 M | 4.710 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 238.161 M | 232.606 M | 190.575 M | 424.877 M | 415.296 M | 413.017 M | 394.076 M | 482.074 M | |
| Total liabilities | 96.114 M | 124.434 M | 110.577 M | 98.822 M | 116.869 M | 122.403 M | 146.127 M | 137.206 M | |
| Total current liabilities | 46.879 M | 82.809 M | 76.694 M | 43.911 M | 72.569 M | 89.386 M | 108.070 M | 123.158 M | |
| Accounts Payable | 4.521 M | 8.183 M | 10.190 M | 3.383 M | 7.673 M | 13.684 M | 6.161 M | 9.992 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 5.162 M | 12.959 M | 20.945 M | 0.000 | 10.842 M | 22.060 M | 46.893 M | 71.526 M | |
| Long term debt | 45.258 M | 37.799 M | 30.212 M | 51.399 M | 40.802 M | 29.838 M | 35.051 M | 11.219 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 142.047 M | 108.172 M | 79.998 M | 326.055 M | 298.427 M | 290.614 M | 247.949 M | 344.868 M | |
| Common stock | 403.869 M | 405.237 M | 381.966 M | 544.459 M | 547.281 M | 579.508 M | 611.333 M | 603.493 M | |
| Retained earnings | -1.330 B | -1.371 B | -1.414 B | -1.452 B | -1.501 B | -1.546 B | -1.598 B | -1.653 B |